Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
China Botanic Hosts Technical Exchange for Industry Research Experts 2011-10-25 20:00
China Medical Technologies Recently Received Approximately 2,200,000 of its ADSs from Two Banks which Borrowed the ADSs in Connection With the Issuance of the Company's Convertible Notes in August 2008 2011-10-25 16:30
China Biologic Named to Asia's "200 Best Under a Billion" by Forbes Asia 2011-10-24 20:03
WuXi PharmaTech Acquires China-Based Clinical Research Services Companies 2011-10-24 20:00
ShangPharma Purchases Shanghai In-vivo Drug Research Facility from Charles River 2011-10-24 20:00
3SBio Inc. Schedules Unaudited Third Quarter 2011 Results 2011-10-20 14:59
China Botanic Appoints Zack Zibing Pan as an Independent Director and Chairman of its Audit Committee 2011-10-18 20:00
China Botanic Announces Results of Annual General Meeting 2011-10-17 20:00
ShangPharma Corporation Announces Shareholder Resolutions Adopted at 2011 Annual General Meeting 2011-10-14 19:00
ShangPharma Corporation Announces Resignation of a Director 2011-10-14 19:00
China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 19, 2011 2011-10-14 19:00
WuXi PharmaTech Acquires Abgent, a Leading Producer of Biological Research Reagents 2011-10-14 09:00
China Sky One Medical, Inc. Elects Board Directors at its Annual Shareholders Meeting 2011-10-13 21:00
Sinovac Selected by Beijing CDC to Supply Seasonal Influenza Vaccine Anflu(R) to Beijing Citizens 2011-10-13 20:00
China Botanic Announces Annual General Meeting of Stockholders 2011-10-13 20:00
China Medical Technologies Receives Two Patents Granted by the UKIPO and Notice of Allowance for Four Patent Applications from the USPTO 2011-10-11 20:00
Huifeng Bio-Pharmaceutical Technology, Inc. to Attend 2011 CPhI Frankfurt 2011-10-10 19:00
VacChina 2011 International Conference Meets in Shanghai This November 2011-10-09 20:15
American Oriental Bioengineering, Inc. Submitted Its Plan to Cure Stock Price Deficiency with Respect to NYSE Listing Standard 2011-10-07 05:00
China Biologic Announces Changes in Directors 2011-10-07 04:30
1 429 430 431 432 433 440